跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NGI-1
首页
药物
NGI-1
NGI-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Tiotropium bromide powder inhalation and preparation method thereof
CN 103110584 A
申请人: UNIV QINGDAO
优先权: 2013
CN
NEW METHOD FOR TREATING DENGUE VIRUS INFECTION
US 20240216345 A1
申请人: INST NAT SANTE RECH MED
优先权: 2023
US
Screening method of glycosylated protein source polypeptide and polypeptide vaccine combination
CN 118604347 A
申请人: INST OF BASIC MEDICAL AND ONCOLOGY CHINESE ACADEMY OF SCIENCES
优先权: 2024
CN
Synthesis method and application of oligosaccharide transferase catalytic subunit inhibitor NGI-1 or derivative thereof
CN 121949238 A
申请人: UNIV QINGDAO SCIENCE & TECHNOLOGY
优先权: 2025
CN
Application of substituted benzamide in preparation of medicine for preventing or treating non-alcoholic fatty liver disease
CN 121695153 A
申请人: UNIV BEIJING
优先权: 2026
CN
Application of bombyx mori TUSC3 gene in prevention and treatment of bombyx mori nuclear polyhedrosis virus infection
CN 122124247 A
申请人: UNIV JIANGSU SCIENCE & TECH
优先权: 2026
CN
药物
反馈